4-[2-(4-甲氧基苯基)乙基]苯胺 | 14802-10-9

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 二苯乙烯类
• 中文名称: 4-[2-(4-甲氧基苯基)乙基]苯胺
• 英文名称: 4-[2-(4-methoxyphenyl)ethyl]aniline
• 英文别名: 4-amino-4'-methoxydiphenylethane；4-(4-methoxyphenethyl)aniline；4-Amino-4'-methoxy-bibenzyl
• CAS: 14802-10-9
• 化学式: C₁₅H₁₇NO
• 分子量: 227.306
• InChiKey: VDAMOOIQBFTFRL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  35.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  4-[2-(4-甲氧基苯基)乙基]苯胺 在 三溴化硼 作用下， 以 二氯甲烷 为溶剂， 以42%的产率得到4-[2-(4-氨基苯基)乙基]苯酚
  参考文献：
  名称：

  Correspondence between Molecular Functionality and Crystal Structures. Supramolecular Chemistry of a Family of Homologated Aminophenols

  摘要：

  The crystal structures and packing features of a family of 13 aminophenols, or supraminols, are analyzed and correlated. These compounds are divided into three groups: (a) compounds 1-5 with methylene spacers of the general type HO-C6H4-(CH2)(n)-C6H4-NH2 (n = 1 to 5) and both OH and NH2 in a para position; (b) compounds 1 a, 2a, 2b, 2c, and 3a in which one or more of the methylene linkers in 1 to 3 are exchanged with an S-atom; and (c) compounds 2d, 1b, and 6a prepared with considerations of crystal engineering and where the crystal structures may be anticipated on the basis of structures 1-5, 1 a, 2a, 2b, 2c, and 3a. These 13 aminols can be described in terms of three major supramolecular synthons based on hydrogen bonding between OH and NH2 groups: the tetrameric loop or square motif, the infinite N(H)O chain, and the beta-As sheet. These three synthons are not completely independent of each other but interrelate, with the structures tending toward the more stable beta-As sheet in some cases. Compounds 1-5 show an alternation in melting points, and compounds with n = even exhibit systematically higher melting points compared to those with n = odd. The alternating melting points are reflected in, and explained by, the alternation in the crystal structures. The n = odd structures tend toward the beta-As sheet as n increases and can be considered as a variable series whereas for n = even, the beta-As sheet is invariably formed constituting a fixed series. Substitution of a methylene group by an isosteric S-atom may causes a change in the crystal structure. These observations are rationalized in terms of geometrical and chemical effects of the functional groups. This study shows that even for compounds with complex crystal structures the packing may be reasonably anticipated provided a sufficient number of examples are available.

  DOI：

  10.1021/ja037227p
• 作为产物：
  描述：

  1-methoxy-4-[2-(4-nitrophenyl)ethenyl]benzene 在 palladium 10% on activated carbon 、 氢气 作用下， 以 乙酸乙酯 为溶剂， 以91%的产率得到4-[2-(4-甲氧基苯基)乙基]苯胺
  参考文献：
  名称：

  沙利度胺衍生的苯乙基苯基邻苯二甲酰亚胺类似物的抗流感活性

  摘要：

  源自猪的甲型流感病毒已在​​全世界引起大流行，甲型流感被认为是严重的全球健康问题。因此，非常需要靶向这些病毒的新型药物。甲型流感病毒表达对其转录和复制必不可少的RNA聚合酶，该酶包含PA，PB1和PB2亚基。我们从34种合成的来自沙利度胺的苯乙基苯基邻苯二甲酰亚胺类似物（PPT类似物）的筛选中鉴定出潜在的新型抗流感药。对于此筛选，我们使用了PA核酸内切酶抑制测定，PB2致病性决定域结合测定和抗A型流感病毒测定。发现三种PPT类似物PPT-65，PPT-66和PPT-67均能抑制PA核酸内切酶活性并延缓甲型流感的生长，表明它们的活性之间存在相关性。还发现PPT-28抑制甲型流感的生长。这四个类似物共有3,4-二羟基苯乙基。我们还讨论了3,4-二羟基苯乙基柔韧性可能在PA核酸内切酶抑制中起重要功能作用的可能性。另一个带有二甲氧基苯乙基的类似物PPT-62具有PB2致病性决定域结合活性，但没有抑

  DOI：

  10.1016/j.bmc.2010.05.035

文献信息

• The synthesis and structure–activity relationship of substituted N-phenyl anthranilic acid analogs as amyloid aggregation inhibitors
  作者：Lloyd J. Simons、Bradley W. Caprathe、Michael Callahan、James M. Graham、Takenori Kimura、Yingjie Lai、Harry LeVine、William Lipinski、Annette T. Sakkab、Yoshikazu Tasaki、Lary C. Walker、Tomoyuki Yasunaga、Yuyang Ye、Nian Zhuang、Corinne E. Augelli-Szafran

  DOI：10.1016/j.bmcl.2008.12.049

  日期：2009.2

  Alzheimer’s disease. In the course of our studies to identify β-amyloid aggregation inhibitors, a series of N-phenyl anthranilic acid analogs were synthesized and studied for β-amyloid inhibition activity. The synthesis, structure–activity relationship, and in vivo activity of these analogs are discussed.

  认为β-淀粉样蛋白聚集是阿尔茨海默氏病发展中的重要事件。在我们鉴定β-淀粉样蛋白聚集抑制剂的研究过程中，合成了一系列N-苯基邻氨基苯甲酸类似物，并研究了β-淀粉样蛋白抑制活性。讨论了这些类似物的合成，结构-活性关系以及体内活性。
• Development of Tetrachlorophthalimides as Liver X Receptor β (LXRβ)-Selective Agonists
  作者：Sayaka Nomura、Kaori Endo-Umeda、Makoto Makishima、Yuichi Hashimoto、Minoru Ishikawa

  DOI：10.1002/cmdc.201600305

  日期：2016.10.19

  lipogenesis in liver, and selective LXRβ activation improves RCT in mice. Therefore, LXRβ‐selective agonists are promising candidates to improve atherosclerosis without increasing plasma or hepatic TG levels. However, the ligand‐binding domains in the two LXR isoforms α/β share high sequence identity, and few LXR ligands show subtype selectivity. In this study we identified a tetrachlorophthalimide analogue

  肝X受体（LXR）激动剂是通过诱导ABCA1（ATP结合盒A1）基因表达来治疗动脉粥样硬化的候选药物，该基因表达有助于逆转胆固醇转运（RCT）并促进肝脏和肠道中胆固醇的排出。但是，LXR激动剂也会诱导参与脂肪形成的基因，例如SREBP-1c（固醇调节结合元件蛋白1c）和FAS（脂肪酸合酶），从而引起血浆和肝甘油三酯（TG）水平的不良增加。最近的研究表明，LXRα有助于肝脏中的脂肪生成，选择性LXRβ活化可改善小鼠的RCT。因此，LXRβ选择性激动剂有望在不增加血浆或肝TG水平的情况下改善动脉粥样硬化。但是，两个LXR同工型α/β中的配体结合结构域具有较高的序列同一性，几乎没有LXR配体显示出亚型选择性。在这项研究中，我们确定了四氯邻苯二甲酰亚胺类似物作为LXRβ选择性激动剂。结构发展导致（E）-4,5,6,7-四氯-2-（2-苯乙烯基苯基）异吲哚啉-1,3-二酮（24 a），这在报告基因测
• Design and Synthesis of Phthalimide-Based Fluorescent Liver X Receptor Antagonists
  作者：Kenji Kishida、Atsushi Aoyama、Yuichi Hashimoto、Hiroyuki Miyachi

  DOI：10.1248/cpb.58.1525

  日期：——

  Based on our structure–activity relationship study of liver X receptor (LXR) ligands, we designed and synthesized fluorescent LXR antagonists containing an unsubstituted or substituted amino group on a phthalimide unit.

  基于我们对肝X受体（LXR）配体的构效关系研究，我们设计并合成了邻苯二甲酰亚胺单元上含有未取代或取代的氨基的荧光LXR拮抗剂。
• Pentaerythritdiphosphite, Verfahren zu deren Herstellung und deren Verwendung als Stabilisatoren
  申请人：CIBA-GEIGY AG

  公开号：EP0186628A2

  公开（公告）日：1986-07-02

  Pentaerythritdiphosphite der Formel worin R, und R, unabhängig voneinander Alkyl mit 1 bis 8 Kohlenstoffatomen, R, -A-COOR4, A eine direkte Bindung, Methylen oder Aethylen und R, Methyl oder Alkyl mit 12 bis 18 Kohienstoffatomen bedeuten. Sie sind zur Stabilisierung organischer Materialien gegen thermischen, oxidativen und aktinischen Abbau verwendbar.

  季戊四醇二亚磷酸酯的化学式中，R 和 R 各自表示具有 1 至 8 个碳原子的烷基，R，-A-COOR4，A 表示直接键、亚甲基或亚乙基，R，甲基或具有 12 至 18 个碳原子的烷基。 它们可用于稳定有机材料，防止热降解、氧化降解和光降解。
• Novel enolamides, process for their manufacture and pharmaceutical compositions thereof with an activity as modulators of the arachidonic acid cascade
  申请人：WARNER-LAMBERT COMPANY

  公开号：EP0221345A1

  公开（公告）日：1987-05-13

  The present invention relates to novel enolamide type compounds, pharmaceutical compositions, and methods of use thereof, useful in the treatment of diseases in which products of lipoxygenase enzyme activity or the action of leukotrienes contribute to the pathological condition.

  本发明涉及新型烯酰胺类化合物、药物组合物及其使用方法，可用于治疗脂氧合酶酶活性产物或白三烯作用导致病理状态的疾病。